Shigeru Hirano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shigeru Hirano has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Charles N. Ford
Division of Otolaryngology—Head and Neck Surgery, Department of Surgery, University of Wisconsin‐Madison, Madison, Wisconsin, U.S.A.
2 shared publicationsDiane M. Bless
Division of Otolaryngology—Head and Neck Surgery, Department of Surgery, University of Wisconsin‐Madison, Madison, Wisconsin, U.S.A.
2 shared publications- Alejandro Munoz del Rio
Department of Radiology, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison WI 53792
1 shared publication Bernard Rousseau
1 shared publicationDouglas Montequin
Department of Surgery, Division of Otolaryngology—Head and Neck Surgery, University of Wisconsin-Madison, Madison, Wisconsin
1 shared publicationNadine P. Connor
Division of Otolaryngology—Head and Neck Surgery, Department of Surgery, University of Wisconsin‐Madison, Madison, Wisconsin, U.S.A.
1 shared publication
Latest Publications
- 1 December 2004
- Published by Wiley in The Laryngoscope
- Vol. 114 (12) , 2161-2167
Therapeutic Potential of Growth Factors for Aging Voice
Objectives/Hypothesis: It has been reported that in aged vocal folds, dense collagen deposition takes place and hyaluronic acid decreases in the lamina propria, which are thought to contribute to the vocal problems occurring with age (presbyphonia). To restore aged vocal folds to their younger state, it seems crucial to address these age‐related lamina propria changes. Intervention that might increase hyaluronic acid and decrease collagen would appear to be a potentially useful approach. The present study examined the effects of growth factors on aged fibroblasts in terms of the production of hyaluronic acid and collagen type I.Study Design: In vitro study using animal model.Methods: Fibroblasts were harvested from young and aged rat vocal folds and cultured with or without hepatocyte growth factor and/or basic fibroblast growth factor at different concentrations. Subsequently, the production of hyaluronic acid and collagen type I was examined in the supernatant culture media using enzyme‐linked immunosorbent assay.Results: Aged fibroblasts produced less hyaluronic acid than younger fibroblasts. When aged and young fibroblasts were cultured with basic fibroblast growth factor, hyaluronic acid production increased and collagen type I production decreased regardless of the concentration, whereas the effects of hepatocyte growth factor appeared to vary with concentration. The basic fibroblast growth factor also was associated with stimulation of growth of aged fibroblasts.Conclusion: The present results suggest that growth factors, especially basic fibroblast growth factor, may have therapeutic potential in restoration of aged vocal fold.
- 1 December 2004
- Published by Wiley in The Laryngoscope
- Vol. 114 (12) , 2161-2167
Therapeutic Potential of Growth Factors for Aging Voice
Objectives/Hypothesis: It has been reported that in aged vocal folds, dense collagen deposition takes place and hyaluronic acid decreases in the lamina propria, which are thought to contribute to the vocal problems occurring with age (presbyphonia). To restore aged vocal folds to their younger state, it seems crucial to address these age‐related lamina propria changes. Intervention that might increase hyaluronic acid and decrease collagen would appear to be a potentially useful approach. The present study examined the effects of growth factors on aged fibroblasts in terms of the production of hyaluronic acid and collagen type I.Study Design: In vitro study using animal model.Methods: Fibroblasts were harvested from young and aged rat vocal folds and cultured with or without hepatocyte growth factor and/or basic fibroblast growth factor at different concentrations. Subsequently, the production of hyaluronic acid and collagen type I was examined in the supernatant culture media using enzyme‐linked immunosorbent assay.Results: Aged fibroblasts produced less hyaluronic acid than younger fibroblasts. When aged and young fibroblasts were cultured with basic fibroblast growth factor, hyaluronic acid production increased and collagen type I production decreased regardless of the concentration, whereas the effects of hepatocyte growth factor appeared to vary with concentration. The basic fibroblast growth factor also was associated with stimulation of growth of aged fibroblasts.Conclusion: The present results suggest that growth factors, especially basic fibroblast growth factor, may have therapeutic potential in restoration of aged vocal fold.
- 1 March 2004
- Published by Wiley in The Laryngoscope
- Vol. 114 (3) , 548-556
Prevention of Vocal Fold Scarring by Topical Injection of Hepatocyte Growth Factor in a Rabbit Model
Objectives/Hypothesis Vocal fold scarring disrupts the layer structure of the vocal fold lamina propria that is essential for optimal mucosal vibration. Prevention of vocal fold scarring remains challenging. Hepatocyte growth factor (HGF) has strong antifibrotic activity. The authors' previous studies have found that HGF stimulates hyaluronic acid production and suppresses collagen production from vocal fold fibroblasts, suggesting that HGF has therapeutic potential in prevention of vocal fold scarring. The present study aimed to demonstrate the effects of HGF on vocal fold scarring in an in vivo rabbit model.Study Design Animal experiment.Methods The vocal fold mucosa was stripped unilaterally in 20 rabbits, then HGF or saline (sham‐treated group) was immediately injected into the injured site. At 6 months after the procedure, histological, rheological, and physiological examinations of vibratory behavior were completed.Results Histological examination revealed excessive collagen deposition and disorganized elastin in the sham‐treated group, whereas the HGF‐treated group presented with better wound healing exhibiting less collagen deposition. Contraction of the injured vocal folds observed in the sham‐treated group did not occur in the HGF‐treated group. Rheological data indicated that the HGF‐treated vocal folds were less stiff and viscous compared with the sham‐treated group. Mucosal vibration of HGF‐treated vocal folds appeared much better than the sham‐treated group in terms of phonation threshold pressure, vocal efficiency, mucosal wave amplitude, and glottal closure.Conclusion Hepatocyte growth factor proved to be useful in preventing vocal fold scarring and maintaining viscoelastic shear properties of the vocal fold.
- 1 March 2004
- Published by Wiley in The Laryngoscope
- Vol. 114 (3) , 548-556
Prevention of Vocal Fold Scarring by Topical Injection of Hepatocyte Growth Factor in a Rabbit Model
Objectives/Hypothesis Vocal fold scarring disrupts the layer structure of the vocal fold lamina propria that is essential for optimal mucosal vibration. Prevention of vocal fold scarring remains challenging. Hepatocyte growth factor (HGF) has strong antifibrotic activity. The authors' previous studies have found that HGF stimulates hyaluronic acid production and suppresses collagen production from vocal fold fibroblasts, suggesting that HGF has therapeutic potential in prevention of vocal fold scarring. The present study aimed to demonstrate the effects of HGF on vocal fold scarring in an in vivo rabbit model.Study Design Animal experiment.Methods The vocal fold mucosa was stripped unilaterally in 20 rabbits, then HGF or saline (sham‐treated group) was immediately injected into the injured site. At 6 months after the procedure, histological, rheological, and physiological examinations of vibratory behavior were completed.Results Histological examination revealed excessive collagen deposition and disorganized elastin in the sham‐treated group, whereas the HGF‐treated group presented with better wound healing exhibiting less collagen deposition. Contraction of the injured vocal folds observed in the sham‐treated group did not occur in the HGF‐treated group. Rheological data indicated that the HGF‐treated vocal folds were less stiff and viscous compared with the sham‐treated group. Mucosal vibration of HGF‐treated vocal folds appeared much better than the sham‐treated group in terms of phonation threshold pressure, vocal efficiency, mucosal wave amplitude, and glottal closure.Conclusion Hepatocyte growth factor proved to be useful in preventing vocal fold scarring and maintaining viscoelastic shear properties of the vocal fold.